John R Moore Edgewise Therapeutics, Inc. (EWTX) insider trading activity

John R Moore is General Counsel of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 3,252 shares of EWTX, which is worth approximately $75,674. The most recent transaction as insider was on Jun 21, 2022, when has been sold 31,078 shares (Common Stock) at a price of $7.29 per share, resulting in proceeds of $226,559. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.25K

0% 3M change

Infinity% 12M change

Total Value Held $75,674

JOHN R MOORE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 21 2022	SELL Open market or private sale	$226,559 $7.29 p/Share	31,078 Reduced 91.2%	3,000 Common Stock
Jun 21 2022	BUY Exercise of conversion of derivative security	$41,023 $1.32 p/Share	31,078 Added 47.7%	34,078 Common Stock
Jun 17 2022	SELL Open market or private sale	$146,481 $6.62 p/Share	22,127 Reduced 88.06%	3,000 Common Stock
Jun 17 2022	BUY Exercise of conversion of derivative security	$42,705 $1.93 p/Share	22,127 Added 46.83%	25,127 Common Stock
Jun 16 2022	SELL Open market or private sale	$90,835 $6.17 p/Share	14,722 Reduced 83.07%	3,000 Common Stock
Jun 16 2022	BUY Exercise of conversion of derivative security	$28,413 $1.93 p/Share	14,722 Added 45.38%	17,722 Common Stock
Jun 15 2022	SELL Open market or private sale	$114,013 $6.11 p/Share	18,660 Reduced 86.15%	3,000 Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	$24,631 $1.32 p/Share	18,660 Added 46.28%	21,660 Common Stock
Jun 14 2022	SELL Open market or private sale	$21,841 $6.02 p/Share	3,628 Reduced 54.74%	3,000 Common Stock
Jun 14 2022	BUY Exercise of conversion of derivative security	$2,576 $0.71 p/Share	3,628 Added 35.37%	6,628 Common Stock
Jun 13 2022	SELL Open market or private sale	$24,599 $6.01 p/Share	4,093 Reduced 57.7%	3,000 Common Stock
Jun 13 2022	BUY Exercise of conversion of derivative security	$2,906 $0.71 p/Share	4,093 Added 36.59%	7,093 Common Stock
Jun 10 2022	SELL Open market or private sale	$43,106 $6.05 p/Share	7,125 Reduced 70.37%	3,000 Common Stock
Jun 10 2022	BUY Exercise of conversion of derivative security	$5,059 $0.71 p/Share	7,125 Added 41.3%	10,125 Common Stock
Jun 09 2022	SELL Open market or private sale	$49,421 $6.49 p/Share	7,615 Reduced 71.74%	3,000 Common Stock
Jun 09 2022	BUY Exercise of conversion of derivative security	$5,407 $0.71 p/Share	7,615 Added 41.77%	10,615 Common Stock
Jun 08 2022	SELL Open market or private sale	$83,313 $6.63 p/Share	12,566 Reduced 80.73%	3,000 Common Stock
Jun 08 2022	BUY Exercise of conversion of derivative security	$8,922 $0.71 p/Share	12,566 Added 44.67%	15,566 Common Stock
Jun 07 2022	SELL Open market or private sale	$119,793 $6.61 p/Share	18,123 Reduced 85.8%	3,000 Common Stock
Jun 07 2022	BUY Exercise of conversion of derivative security	$23,922 $1.32 p/Share	18,123 Added 47.35%	20,150 Common Stock
Jun 06 2022	SELL Open market or private sale	$84,022 $6.03 p/Share	13,934 Reduced 82.28%	3,000 Common Stock
Jun 06 2022	BUY Exercise of conversion of derivative security	$26,893 $1.93 p/Share	13,934 Added 45.14%	16,934 Common Stock
Jun 03 2022	SELL Open market or private sale	$92,142 $6.05 p/Share	15,230 Reduced 83.54%	3,000 Common Stock
Jun 03 2022	BUY Exercise of conversion of derivative security	$29,394 $1.93 p/Share	15,230 Added 45.52%	18,230 Common Stock
May 16 2022	SELL Open market or private sale	$80,136 $7.42 p/Share	10,800 Reduced 78.26%	3,000 Common Stock

JRM

John R Moore

General Counsel

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX

Account